Technical Analysis for SFE - Safeguard Scientifics, Inc.
|Grade||Last Price||% Change||Price Change|
SFE closed down 2.91 percent on Tuesday, January 15, 2019, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical SFE trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 15||Bearish Engulfing||Bearish||0.00%|
|Jan 15||Multiple of Ten Bearish||Other||0.00%|
|Jan 15||Outside Day||Range Expansion||0.00%|
|Jan 15||Overbought Stochastic||Strength||0.00%|
|Jan 14||New Uptrend||Bullish||-2.91%|
|Jan 14||Narrow Range Bar||Range Contraction||-2.91%|
|Jan 14||Overbought Stochastic||Strength||-2.91%|
|Jan 14||Up 3 Days in a Row||Strength||-2.91%|
|Jan 11||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||-1.93%|
|Jan 11||Outside Day||Range Expansion||-1.93%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Safeguard Scientifics, Inc. is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. The firm prefers to make investments in companies engaged in the technology and life sciences sectors. Within the technology sector, it invests in software as a service, enterprise 3.0, technology enabled services, internet/new media, financial services information technology, medtech, healthcare information technology and selected business services with capital requirements of up to $25 million. Within the life sciences sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, and specialty pharmaceuticals, and selected healthcare services. It invests throughout United States and Southeastern Canada. The firm primarily invests between $10 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of five percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. It was formerly known as Lancaster Corporation. Safeguard Scientifics, Inc. was founded in 1953 and is based in Wayne, Pennsylvania with an additional office in Weston, Massachusetts.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more SFE news...
|52 Week High||13.95|
|52 Week Low||7.98|
|200-Day Moving Average||10.7665|
|50-Day Moving Average||8.7704|
|20-Day Moving Average||8.929|
|10-Day Moving Average||9.364|
|Average True Range||0.3417|
|Chandelier Exit (Long, 3 ATRs )||8.9949|
|Chandelier Exit (Short, 3 ATRs )||9.0151|
|Upper Bollinger Band||10.1324|
|Lower Bollinger Band||7.7256|
|Percent B (%b)||0.81|
|MACD Signal Line||0.1456|
|Market Cap||197.6 Million|
|Num Shares||20.4 Million|
|Price-to-Earnings (P/E) Ratio||-1.99|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||10.27|
|Resistance 3 (R3)||10.31||10.17||10.17|
|Resistance 2 (R2)||10.17||10.02||10.14||10.13|
|Resistance 1 (R1)||9.92||9.93||9.85||9.88||10.10|
|Support 1 (S1)||9.53||9.63||9.46||9.49||9.26|
|Support 2 (S2)||9.39||9.54||9.36||9.23|
|Support 3 (S3)||9.14||9.39||9.19|
|Support 4 (S4)||9.10|